| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/26/2010 | CN101711513A Method for increasing sow ovulation rate and injection thereof |
| 05/26/2010 | CN101147807B Substances for preventing and treating autoimmune diseases |
| 05/26/2010 | CN101057976B Substances for preventing and treating autoimmune diseases |
| 05/26/2010 | CN101040847B Nanometer medicine agent produced by hydrogenated castor oil and the technique of preparing the same |
| 05/26/2010 | CN101020715B Process of extracting and preparing deer nerve growth factor (DEER NGF) |
| 05/26/2010 | CN101019836B Nanometer cytochrome liposome medicine and its preparation |
| 05/26/2010 | CA2645749A1 Soy kefir powder and uses thereof |
| 05/25/2010 | USRE41356 Hepatitis C inhibitor tri-peptides |
| 05/25/2010 | US7723563 Transgenic proteins from multi-gene systems, methods, compositions, uses and the like relating thereto |
| 05/25/2010 | US7723510 MicroRNA molecules |
| 05/25/2010 | US7723508 Modulation of apolipoprotein (A) expression |
| 05/25/2010 | US7723501 polynucleotides tht code for Bcl-2 associated athanogenes (BAG), a family of proteins that can regulate protein folding, useful in modulating chaperone protein activity |
| 05/25/2010 | US7723499 polynucleotides that code for polypeptides comprising amino acid sequences that preferentially recognize and bind to angiopoietins |
| 05/25/2010 | US7723497 polynucleotide having nucleic acid sequences, encoding and expressing calcium-independent phospholipase A2 epsilon (iPLA2 epsilon ); for catalysis and hydrolysis of lipids in living cell biosystem; iPLA2 epsilon as a pharmacological target in drug screening anti-obesity drugs |
| 05/25/2010 | US7723496 Tumor antigen for diagnosis and treatment of cell proliferative disorders |
| 05/25/2010 | US7723490 Process for correction of a disulfide misfold in Fc molecules |
| 05/25/2010 | US7723488 Monoclonal antibody for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 05/25/2010 | US7723483 An antibody binding to the cysteine loop domain at amino acids 177-184 of a human or pig beta 3 integrin (Amino Acid SEQ ID NO: 82); does not bind to the RGD binding site of a human beta 3 integrin or utilize the RGD binding site of human beta 3 integrin; side effect reduction; nontoxic |
| 05/25/2010 | US7723482 Preventing CD28 binding to B7 by monovalent fragments antibody called CD28.3 of which exhibit sufficient affinity for the antigen so that they can be used, in vitro or in vivo, to block the CD28 receptor without activation of this receptor; autoimmune diseases; transplant rejection |
| 05/25/2010 | US7723480 Leucine-based motif and clostridial neurotoxins |
| 05/25/2010 | US7723479 BSL3 polypeptides |
| 05/25/2010 | US7723478 DKR polypeptides |
| 05/25/2010 | US7723477 Frizzled receptor specific immunoglobulin for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 05/25/2010 | US7723476 Anticalins |
| 05/25/2010 | US7723475 isolated nucleic acid molecule encoding polypeptide as antitumor biodrugs; monoclonal antibody; modulation of chemokine, cytokine expression; transfected host cell; anticarcinogenic agents |
| 05/25/2010 | US7723474 Molecules that selectively home to vasculature of pre-malignant dysplastic lesions or malignancies |
| 05/25/2010 | US7723471 Useful in the treatment and prevention of metabolic disorders; promote weight loss; hypotensive, antisecretory, and gastroprotective agents |
| 05/25/2010 | US7723470 Antibiotic of given structure; vancomycin derivatives; enhanced activity, selectivity and reduced mammalian toxicity |
| 05/25/2010 | US7723469 Treating leukemia by administering a cross-linked polypeptide antiapoptosis agent having at least two modified amino acids ("hydrocarbon stapling"); crosslinking increases cell permeability |
| 05/25/2010 | US7723468 Antimicrobial peptide, compositions, and uses therefor |
| 05/25/2010 | US7723467 Antimicrobial compounds |
| 05/25/2010 | US7723390 Thyroid hormones or their salts in capsule or in swallowable uniform soft-gel gelatin matrices for treatment of hypothyroidism |
| 05/25/2010 | US7723361 Kaposi's sarcoma; Crohn's disease; combination therapy with an epoxide hydrolase inhibitor |
| 05/25/2010 | US7723357 Thalidomide and thalidomide derivatives for treating spinal disorders mediated by nucleus pulposus |
| 05/25/2010 | US7723313 via pigment epithelium derived growth factor; inhibition of neuroblastoma growth |
| 05/25/2010 | US7723308 Plant-derived elastin binding protein ligands and methods of using the same |
| 05/25/2010 | US7723307 transglutaminase inhibitor; fibrosis, scarring, neurodegenerative diseases, autoimmune diseases, thrombosis, proliferative disorders, AIDS, psoriasis, inflammation; N-Benzyloxycarbonyl-L-phenylalanyl-6-dimethylsulfonium-5-oxo-L-norleucine; 6-diazo-5-oxo-L-norleucine reacted with N-protected amino acid |
| 05/25/2010 | US7723306 such as glucosyl and maltosyl sucrose; storage stability |
| 05/25/2010 | US7723305 Abuse-resistant amphetamine prodrugs |
| 05/25/2010 | US7723304 Hypotensive agents; cardiovascular disorders; wound healing agents; antitumor agents; antidiabetic agents ; nephropathy; gastrointestinal disorders; alopecia; blood disorders ; urogenital disorders |
| 05/25/2010 | US7723303 Peptides and peptide mimetics to treat pathologies characterized by an inflammatory response |
| 05/25/2010 | US7723302 Method of treating Parkinson's disease |
| 05/25/2010 | US7723301 administering Noggin proteins to reduce teratogenicity of antineoplastic agents; antibodies |
| 05/25/2010 | US7723300 Regulators of the non-genomic action of progesterone and methods of use |
| 05/25/2010 | US7723299 Methods for treating rheumatoid arthritis using a CTLA-4 fusion protein |
| 05/25/2010 | US7723298 Cytokine receptor |
| 05/25/2010 | US7723297 relates to nucleic acid sequences encoding a member of the fibroblast growth factor (FGF) family, and to polypeptides encoded by the nucleic acid sequence |
| 05/25/2010 | US7723295 Peptides and compounds that bind to a receptor |
| 05/25/2010 | US7723294 Adjacent hybrid peptide layers covalently bonded by a non-peptidic linkage; improved biofunctionality; drug delivery microcapsules |
| 05/25/2010 | US7723293 administering to the heart of subject in need of increased capillary density in the heart a trk receptor ligand in an amount effective to increase capillary density in the heart, said trk receptor ligand being selected from the group consisting of brain-derived neurotrophic factor, NT-3, and NT-4. |
| 05/25/2010 | US7723292 Detection and treatment of neoplasia; human C3 convertase from snake venom; C3convertase inhibitors from animal serum; kits; ACP/ANDS (Alternative Complement Pathway/Against Neoplasm Defending System) |
| 05/25/2010 | US7723291 Promoting bone growth by placing a carrier matrix of a collagen sponge and a pump that can deliver bone morphogenetic protein 2 (and optionally another bone growth promoter) at a patient's target site and connecting the pump within the matrix; protocol can be used for slow-to-heal fractures |
| 05/25/2010 | US7723290 Preimplantation factor; ulcerative colitis, Chron's disease, type i diabetes, graft-versus-host disease |
| 05/25/2010 | US7723289 Preimplantation factor; graft-versus-host disease; enhance endometrial receptivity, blocking activated but not basal immunity, inhibiting cell proliferation and creating a TH2 type cytokine bias |
| 05/25/2010 | US7723287 treating damaged eye epithelium or cornea or anterior segment of eye by administering a high-density lipoprotein and a combination of non-cholesterol lipid components capable of reconstituting a high-density lipoprotein comprising sphingolipid and phospholipid and a glyceride and a triglyceride |
| 05/25/2010 | US7723096 Agonist peptides of carcinoembryonic antigen (CEA) and nucleic acid sequences encoding the agonist peptides |
| 05/25/2010 | US7723091 combination of a mannanase and a carrier that is adapted for oral administration and does not contain an anti-infection agent other than the mannanase; treating or ameliorating the risk of a digestive tract infection, particularly of Eimeria, Cryptosporidium, or Clostridium |
| 05/25/2010 | US7723089 PEG-urate oxidase conjugates and use thereof |
| 05/25/2010 | US7723080 Murine α (1,3) fucosyltransferase Fuc-TVII, DNA encoding the same, method for preparing the same, antibodies recognizing the same, immunoassays for detecting the same, plasmids containing such DNA, and cells containing such a plasmid |
| 05/25/2010 | US7723075 Methods of screening for TRPM5 modulators |
| 05/25/2010 | US7723067 Process for producing transglutaminase |
| 05/25/2010 | US7723018 Identifying compounds which inhibit cell cycle progression for use in treating cell proliferative disorders agents for treat; antiproliferative/antitumor agents |
| 05/25/2010 | US7722895 Osteogenic implants with combined implant materials, and materials and methods for same |
| 05/25/2010 | US7722887 detoxified and immunologically active heat-labile enterotoxin protein of Escherichia coli, wherein the serine residue at position 63 is substituted with tyrosine or amino acid residues at positions 110 and 112 are deleted; for development of a mucosal vaccine as well as a novel diarrheal vaccine |
| 05/25/2010 | US7722886 Therapeutic agent comprising cytokine inhibitory activity for use in treatment of respiratory system disorders; viricides; antisense agents; enzyme inhibitors; immunotherapy; RNA interference; recombinant cytokine receptors |
| 05/25/2010 | US7722880 polynucleotide encodes a protein for inducing an immune response; use as vaccines; drug targeting to specific protein; bactericides; veterinary medicine |
| 05/25/2010 | US7722876 Anti-idiotypic antibodies which recognise the idiotope of an antibody specific for a yeast killer toxin possess microbicidal activity |
| 05/25/2010 | US7722874 Methods for reducing T cell responsiveness to an autoantigen with anti-gp39 antibodies and antigen presenting cells |
| 05/25/2010 | US7722870 Method of treating fibroproliferative disorders |
| 05/25/2010 | US7722868 Agents that modulate the interaction of B7-1 polypeptide with PD-L1 and methods of use thereof |
| 05/25/2010 | US7722865 Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof |
| 05/25/2010 | US7722864 Exhibit altered chondroitin lyase activity or increased resistance to inactivation from stressors including exposure to ultraviolet radiation or heat; administered following a contusion or spinal cord injury to the central nervous system |
| 05/25/2010 | US7722863 Use of granzyme b as an hsp70/hsp70 peptide dependent inducer of apoptosis in tumor cells |
| 05/25/2010 | US7722838 device for selecting plurality of precursors to produce a neutralizing substance for a substance to be neutralized, comprising container containing each of precursors, selector capable of selecting precursors, collecting space for receiving precursors, and dispensing mechanism for dispensing neutralizer |
| 05/25/2010 | US7722671 Medical devices with associated growth factors |
| 05/25/2010 | CA2469393C Processes for the measurement of the potency of glatiramer acetate |
| 05/25/2010 | CA2421512C Cosmetic and pharmaceutical compositions and their use |
| 05/25/2010 | CA2376666C Polymorphisms in the human mdr-1 gene and their use in diagnostic and therapeutic applications |
| 05/25/2010 | CA2375923C Devices and compounds for treating arterial restenosis |
| 05/25/2010 | CA2362279C Connective tissue softening |
| 05/25/2010 | CA2361892C Treatment of tumors with genetically engineered herpes virus |
| 05/25/2010 | CA2330237C Broad specificity dna damage endonuclease |
| 05/25/2010 | CA2326874C Methods for reducing cholesterol using bacillus coagulans spores, systems and compositions |
| 05/25/2010 | CA2321964C Artificial chromosome constructs containing nucleic acid sequences capable of directing the formation of a recombinant virus |
| 05/25/2010 | CA2269335C Platelet substitutes and conjugation methods suitable for their preparation |
| 05/25/2010 | CA2238613C Consensus phytases |
| 05/25/2010 | CA2225189C Canine factor viii gene, protein and methods of use |
| 05/25/2010 | CA2218857C Clostridial toxin derivatives able to modify peripheral sensory afferent functions |
| 05/25/2010 | CA2199715C Novel implant and novel vector for the treatment of acquired diseases |
| 05/25/2010 | CA2173130E Glutathione s-transferase-activated compounds |
| 05/20/2010 | WO2010056988A2 Methods of treating stroke using stem cell-like menstrual blood cells |
| 05/20/2010 | WO2010056981A2 Methods and compositions for regulating iron homeostasis by modulation bmp-6 |
| 05/20/2010 | WO2010056880A1 Utrophin promoter activity upregulation for the treatment of muscular dystrophy |
| 05/20/2010 | WO2010056797A1 Phosphopeptide enrichment of compositions by fractionation on ceramic hydroxyapatite |
| 05/20/2010 | WO2010056765A2 Antidotes for factor xa inhibitors and methods of using the same in combination with blood coagulating agents |
| 05/20/2010 | WO2010056735A1 Compositions and methods for inhibiting an oncogenic protein to enhance immunogenicity |
| 05/20/2010 | WO2010056662A1 Activated wnt-beta-catenin signaling in melanoma |
| 05/20/2010 | WO2010056657A2 Low viscosity highly concentrated suspensions |
| 05/20/2010 | WO2010056496A1 Azepinone derivatives |
| 05/20/2010 | WO2010056472A2 Compositions and methods of use for thrombomodulin variants |